Tenax Therapeutics, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2015 | — | $70.4M | $7.9M |
| FY2016 | — | $17.1M | $10.0M |
| FY2017 | — | $8.9M | $1.6M |
| FY2018 | — | $11.8M | $12.4M |
| FY2019 | — | $3.8M | $4.9M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2015 | — | $70.4M | $7.9M |
| FY2016 | — | $17.1M | $10.0M |
| FY2017 | — | $8.9M | $1.6M |
| FY2018 | — | $11.8M | $12.4M |
| FY2019 | — | $3.8M | $4.9M |